The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co shares valued at $2,650,480 were sold by Elkins David V on Sep 02 ’25. At $47.33 per share, Elkins David V sold 56,000 shares. The insider’s holdings dropped to 167,379 shares worth approximately $7.66 million following the completion of this transaction.
Also, Elkins David V purchased 56,000 shares, netting a total of over 2,648,800 in proceeds.
Before that, Short Bartie Wendy had sold 378 shares from its account. In a trade valued at $16,719, the EVP, Corporate Affairs traded Bristol-Myers Squibb Co shares for $44.23 each. Upon closing the transaction, the insider’s holdings decreased to 378 shares, worth approximately $0.23 million.
As published in their initiating research note from Scotiabank on November 13, 2025, Bristol-Myers Squibb Co [BMY] has been a Sector perform and the price target has been revised to $45. Analysts at Daiwa Securities downgraded the stock from ‘”an Outperform”‘ to ‘”a Neutral”‘ outlook in a report released in early August. As of April 22, 2025, Piper Sandler has initiated its “an Overweight” rating for BMY. Earlier on April 22, 2025, Cantor Fitzgerald initiated its rating. Their recommendation was “a Neutral” for BMY stock.
Analyzing BMY Stock Performance
On last trading session, Bristol-Myers Squibb Co [NYSE: BMY] plunged -2.70% to $45.79. The stock’s lowest price that day was $45.74, but it reached a high of $47.0 in the same session. During the last five days, there has been a drop of approximately -6.70%. Over the course of the year, Bristol-Myers Squibb Co shares have dropped approximately -18.55%. Shares of the company reached a 52-week high of $63.33 on 03/11/25 and a 52-week low of $42.52 on 10/29/25.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
According to the 24-hour chart, there is a support level at 45.35, which, if violated, would cause prices to drop to 44.92. In the upper region, resistance lies at 46.61. The next price resistance is at 47.44. RSI (Relative Strength Index) is 48.20 on the 14-day chart, showing neutral technical sentiment.
Is Bristol-Myers Squibb Co subject to short interest?
Stocks of Bristol-Myers Squibb Co saw a sharp rise in short interest on 2025-10-31 jumping by 5.73 million shares to 32.07 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 26.34 million shares. A jump of 17.86% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.72 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.72.
Which companies own the most shares of Bristol-Myers Squibb Co (BMY)?
In terms of Bristol-Myers Squibb Co share price expectations, FactSet research, analysts set an average price target of 63 in the next 12 months, up nearly 33.87% from the previous closing price of $47.06. Analysts anticipate Bristol-Myers Squibb Co stock to reach 84 by 2025, with the lowest price target being 42. In spite of this, 14 analysts ranked Bristol-Myers Squibb Co stock as Hold at the end of 2025. On December 16, 2024, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $70.
